Idifarma provides contract development and manufacturing services for niche and highly potent generic or innovative drugs

Pharmaceutical R&D and Manufacturing Services

Idifarma is an independent, privately-owned pharmaceutical CDMO based in Spain and specializing in highly potent drugs.

With an experienced staff of 130+ people and over 100 international clients, Idifarma provides a full range of services covering most of the lifecycle of any pharmaceutical product from first pre-formulation trials to commercial manufacturing: drug formulation, development and validation of analytical methods, quality control and batch release in the EU, stability studies, regulatory affairs, GMP contract manufacturing and packaging for clinical or commercial use.

Its state-of-the-art facility features a purpose-built high containment plant for GMP manufacturing of oral solid dosage forms, for both highly potent and non-potent drugs.

Idifarma’s expertise, capabilities and proven track record make it the perfect partner for the development of your projects.

NEWS

EVENTS AND CONFERENCES 2020

Idifarma will attend the following events during 2020 Would you like to meet us? Contact us at meet@idifarma.com to schedule a meeting!

LAST TWEETS

Our colleague Javier Aznarez from Business Development will be attending #EuroPLX during 09-10th March in #Berlin.
If you want to arrange a meeting there, contact us at meet@idifarma.com!

#pharma #europlx #cdmo

During next week, @Idifarma will be present at Pharma Synergy Conference (24-25th February, London).

Would you like to arrange a meeting? Contact us at meet@idifarma.com

Idifarma will be present at Pharma Synergy Conference (24-25 February, London).
If you want to arrange a meeting there, contact us at meet@idifarma.com!

https://pharma-synergy-conference.com

Our new capsule weight checking equipment is already operational and working for our next commercial launch of a highly potent drug for a client!

This investment will allow us to ensure the higher quality for capsule manufacturing processes requiring unitary weight control.

⁦@Idifarma⁩ New launches in 2020 https://www.linkedin.com/posts/suanfarma-s%2Ea%2E_idifarma-desarrollo-farmac%C3%A9utico-sl-we-activity-6625342050051072000-RCzP

Load More...

Do you want to receive the latest news from Idifarma?

Utilizamos cookies propias y de terceros para realizar el análisis de la navegación de los usuarios y mejorar nuestros servicios. Si continúa navegando, consideramos que acepta su uso. Puede obtener más información, o bien conocer cómo cambiar la configuración pulse aquí ACEPTAR

Aviso de cookies